Growing evidence indicates that RhoA and its main effector ROCK play a central role in a wide range of cardiovascular diseases such as congestive heart failure, atherosclerosis, and hypertension (Loirand et al., 2006; Hamid et al., 2007; Dong et al., 2010). This evidence concerns the gene RHOA and cardiovascular disorder.